Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 217

Results For "quality"

2396 News Found

Narayana Hrudayalaya to open a hospital in Punjab
Hospitals | December 05, 2021

Narayana Hrudayalaya to open a hospital in Punjab

The hospital is scheduled to open in 2024 with a bed capacity of 225


Motherhood Hospitals opens second center in Pune
News | December 05, 2021

Motherhood Hospitals opens second center in Pune

The first hospital in Kharadi launched three years ago has made a significant difference to women and children's health


Neuberg Diagnostics expands to North India
Clinical Trials | December 03, 2021

Neuberg Diagnostics expands to North India

Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time


Over one lakh SARS-CoV-2 genomes sequenced till November
Policy | December 03, 2021

Over one lakh SARS-CoV-2 genomes sequenced till November

Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry


Sai Life Sciences receive Certificate of Inspection from Japan PMDA
Biotech | December 02, 2021

Sai Life Sciences receive Certificate of Inspection from Japan PMDA

The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product


LifeCell Diagnostics introduces the NovaSeq 6000
Medical Device | December 02, 2021

LifeCell Diagnostics introduces the NovaSeq 6000

One of the very few facilities in India to have this capability, marking a remarkable feat in LifeCell’s expedition to take genome sequencing to the next level in India


Jaslok Hospital launches heart transplant programme in Mumbai
Hospitals | December 01, 2021

Jaslok Hospital launches heart transplant programme in Mumbai

The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok


U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib
Biotech | November 30, 2021

U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib

Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)


AMPATH launches its pathology laboratory in Mumbai
Clinical Trials | November 29, 2021

AMPATH launches its pathology laboratory in Mumbai

The company has has 10 existing labs in India


Pharma firms switch to advanced pharma manufacturing
Supply Chain | November 27, 2021

Pharma firms switch to advanced pharma manufacturing

Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies